Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1548.3000 -26.30 (-1.67%)
NSE Sep 15, 2025 15:31 PM
Volume: 759.0K
 

logo
Cipla Ltd.
11 Nov 2016
1548.30
-1.67%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 9% YoY to | 3751 crore, (I-direct estimate: | 3602 crore) due to strong growth in US and India. US sales grew 38% YoY to | 660 crore (I-direct estimate: | 639 crore). Domestic formulation grew 21% YoY to | 1467 crore (I-direct estimate: | 1338 crore) EBITDA margins declined 460 bps to 18.1% (I-direct estimate: 17.3%) mainly on account of higher other expenditure. EBITDA de-grew 13% YoY to | 681 crore (I-direct estimate: | 625 crore)...
Cipla Ltd. is trading above its 200 day SMA of 1493.1
More from Cipla Ltd.
Recommended